Who owns Inventiva S.A.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IVA from SEC Form 13F filings across 88 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 88 institutions disclosed 84.6M shares of Inventiva S.A. worth $319.5M — about 33.1% of shares outstanding; the largest disclosed holder is Caligan Partners LP. Source: SEC Form 13F filings, parsed by EvidInvest.
88
13F holders
$319.5M
value, 2026 filers
33.1%
of shares outstanding (84.6M sh)
31
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IVA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Caligan Partners LP | 8.2M | $30.9M | 1.5% | 3.2% | +64.1% |
| 2 | SAMSARA BIOCAPITAL, LLC | 6.3M | $23.9M | 2.0% | 2.5% | +21.6% |
| 3 | Paradigm Biocapital Advisors LP | 4.0M | $15.1M | 0.3% | 1.6% | 0.0% |
| 4 | ANDERA PARTNERS | 3.6M | $13.7M | 6.7% | 1.4% | +99.8% |
| 5 | ADAR1 Capital Management, LLC | 3.6M | $13.6M | 0.6% | 1.4% | +65.9% |
| 6 | MILLENNIUM MANAGEMENT LLC | 3.5M | $13.3M | 0.0% | 1.4% | +17.6% |
| 7 | Nantahala Capital Management, LLCNEW | 2.7M | $10.2M | 0.3% | 1.1% | new |
| 8 | Trails Edge Capital Partners, LP | 2.7M | $10.0M | 1.6% | 1% | 0.0% |
| 9 | FRANKLIN RESOURCES INC | 2.6M | $10.0M | 0.0% | 1% | +7.4% |
| 10 | Squadron Capital Management LLC | 2.4M | $9.2M | 2.9% | 1% | +355.1% |
| 11 | Woodline Partners LPNEW | 2.3M | $8.8M | 0.0% | 0.9% | new |
| 12 | Aberdeen Group plcNEW | 2.3M | $8.7M | 0.0% | 0.9% | new |
| 13 | UBS Group AG | 2.3M | $8.7M | 0.0% | 0.9% | -0.6% |
| 14 | BOOTHBAY FUND MANAGEMENT, LLC | 2.0M | $7.6M | 0.1% | 0.8% | +36.3% |
| 15 | Patient Square Capital LPNEW | 2.0M | $7.4M | 1.2% | 0.8% | new |
| 16 | NEXTBio Capital Management LP | 1.8M | $6.8M | 3.1% | 0.7% | +34.1% |
| 17 | CITADEL ADVISORS LLC | 1.8M | $6.7M | 0.0% | 0.7% | +2647.6% |
| 18 | AMERIPRISE FINANCIAL INC | 1.7M | $6.4M | 0.0% | 0.7% | +101.0% |
| 19 | Point72 Asset Management, L.P. | 1.7M | $6.4M | 0.0% | 0.7% | +76.0% |
| 20 | Integral Health Asset Management, LLC | 1.5M | $5.7M | 0.2% | 0.6% | +280.0% |
| 21 | Yu Fan | 1.5M | $5.7M | 5.3% | 0.6% | 0.0% |
| 22 | NEA Management Company, LLC | 1.5M | $5.5M | 0.3% | 0.6% | 0.0% |
| 23 | STEMPOINT CAPITAL LPNEW | 1.4M | $5.4M | 0.9% | 0.6% | new |
| 24 | JPMORGAN CHASE & CONEW | 1.3M | $4.6M | 0.0% | 0.5% | new |
| 25 | Propel Bio Management, LLC | 1.3M | $4.8M | 2.5% | 0.5% | +76.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.